Cargando…

Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development

Renal cell carcinoma (RCC) is one of the leading causes of death in men. Messenger ribonucleic acid (mRNA) vaccines may be an attractive means to achieve satisfactory results. Cancer immunotherapy is a promising cancer treatment strategy. However, immunotherapy is not widely used in renal cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xinglin, Zhang, Tongtong, Zhai, Xinyu, Wan, Zhong, Ge, Minyao, Liu, Chengzong, Tan, Mingyue, Xu, Dongliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669058/ https://www.ncbi.nlm.nih.gov/pubmed/36405755 http://dx.doi.org/10.3389/fimmu.2022.1037808

Ejemplares similares

Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy
por: Chen, Xinglin, et al.
Publicado: (2023)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
por: Zhai, Xinyu, et al.
Publicado: (2023)

Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma
por: Wei, Baojun, et al.
Publicado: (2021)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

Identifying tumor antigens and immune subtypes of gastrointestinal MALT lymphoma for immunotherapy development
por: Jiang, Xinlu, et al.
Publicado: (2022)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Characterization of Different Subtypes of Immune Cell Infiltration in Glioblastoma to Aid Immunotherapy
por: Feng, Peng, et al.
Publicado: (2022)

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
por: Picard, Emilie, et al.
Publicado: (2020)

Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy
por: Wang, Yanan, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
por: Lin, Han, et al.
Publicado: (2022)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Editorial: Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
por: Caserta, Stefano, et al.
Publicado: (2021)

Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties
por: Chen, Zuobing, et al.
Publicado: (2023)

Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas
por: Fang, Wentao, et al.
Publicado: (2021)

Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
por: Wan, Qi, et al.
Publicado: (2022)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

Immune Microenvironment and Response in Prostate Cancer Using Large Population Cohorts
por: Ren, Xiaohan, et al.
Publicado: (2021)

Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma
por: Jian, Yuli, et al.
Publicado: (2021)

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

Damage-associated molecular patterns and sensing receptors based molecular subtypes in malignant pleural mesothelioma and implications for immunotherapy
por: Liu, Zheng, et al.
Publicado: (2023)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer
por: Jiang, Sutian, et al.
Publicado: (2022)

Immune Microenvironment in Glioblastoma Subtypes
por: Chen, Zhihong, et al.
Publicado: (2018)

Immune Subtyping in Latent Tuberculosis
por: Banerjee, Ushashi, et al.
Publicado: (2021)

Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
por: Richardson, Naomi, et al.
Publicado: (2020)

Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
por: Wang, Yuning, et al.
Publicado: (2023)

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
por: Dong, Yan, et al.
Publicado: (2021)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Immune Cell Subtypes and Their Function in the Testis
por: Bhushan, Sudhanshu, et al.
Publicado: (2020)

Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
por: Perales-Linares, Renzo, et al.
Publicado: (2023)

γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy
por: Poggi, Alessandro, et al.
Publicado: (2014)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer
por: Xie, Xiao, et al.
Publicado: (2022)

Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments
por: Wang, Tengda, et al.
Publicado: (2022)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
por: Tan, Ruirong, et al.
Publicado: (2023)

Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
por: Zhang, Ganghua, et al.
Publicado: (2022)

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
por: Kosti, Paris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8tmi4qb9q0jahfsb9se9grfo45